Please login to the form below

Not currently logged in
Email:
Password:

Raxone

This page shows the latest Raxone news and features for those working in and with pharma, biotech and healthcare.

Encouraging data for GenSight’s blinding retinal disease gene therapy

Encouraging data for GenSight’s blinding retinal disease gene therapy

If approved, the gene therapy would compete with Santhera's Raxone, which became the first approved treatment for LHON in Europe in 2015.

Latest news

More from news
Approximately 5 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan...
Patient diversity in clinical trials
The pursuit of patient diversity in clinical trials
When all-inclusive isn’t an option, it’s an obligation...
Overcoming the digital patient recruitment challenges of connecting with patients
How many irrelevant experiences, ads, emails, direct messages have you rejected this week?...